EULAR 2024

2024-06-12 - 2024-06-15
Vienna, Austria

ISTH 2022

2022-07-09 - 2022-07-13
London, United Kingdom

EULAR 2021

2021-06-02 - 2021-06-05
Online, Virtual

Written reports

2020-10-27 - 2020-10-28
Online, Virtual

PAINWeek 2020

2020-09-11 - 2020-09-13
Online, Virtual

EULAR 2020

2020-06-03 - 2020-06-06
Online, Virtual

EASD 2019

2019-09-16 - 2019-09-20
Barcelona, Spain

ESH 2019

2019-06-21 - 2019-06-24
Milan, Italy

EASD 2018

2018-10-01 - 2018-10-05
Berlin, Germany
Search in Scientific Content:
Date
Filters:
75th Anniv
4:59

75th Anniversary of Glucocorticoids - what have we learnt?

Presenter: Sytske Anne Bergstra
EULAR 2024
Update of
4:48

Update of EULAR recommendations for the treatment of Systemic Sclerosis

Presenter: Francesco Del Galdo
EULAR 2024
Promising
5:13

Promising directions in the treatment of Psoriatic Arthritis

Presenter: Rik Lories
EULAR 2024
Interstiti
6:06

Interstitial Lung Disease: from diagnosis to management

Presenter: Anna-Maria Hoffmann-Vold
EULAR 2024
What is Ne
7:12

What is New : Osteoporosis in Rheumatology

Presenter: Willem Lems
EULAR 2024
Effectiven
5:48

Effectiveness of Canakinumab for first line steroid free treatment in systemic juvenile idiopathic arthritis - report from EULAR2024

Presenter: Gerd Horneff
EULAR 2024
Early and
9:21

Early and maintained comparative effectiveness of 5 different classes of advanced therapies in a large multinational cohort of real-world PsA patients

EULAR 2024
Fatigue, P
11:11

Fatigue, Pain and Opioids in Rheumatological Diseases

Presenter: Rene Westhovens
EULAR 2024
Cardiovasc
3:54

Cardiovascular Comorbidities of Rheumatic and Musculoskeletal Diseases

Presenter: Anja Strangfeld
EULAR 2024
Update on
5:00

Update on EULAR/ACR Project: Risk Stratification in patients with arthralgia suspicious for progression to RA

Presenter: Annette H. M. van der Helm van Mil
EULAR 2024
Difficult
9:43

Difficult Questions in Osteoporosis

Presenter: Roland Chapurlat
EULAR 2024
Secukinuma
6:32

Secukinumab versus standard-of-care in axial spondyloarthritis

Presenter: Denis Poddubnyy
EULAR 2024
Lupus: wha
10:48

Lupus: what's on the horizon?

Presenter: David Isenberg
EULAR 2024
Metabolic
6:12

Metabolic Reprogramming in Autoimmunity

Presenter: Valentina Pucino
EULAR 2024
Rheumatoid
6:13

Rheumatoid Arthritis Prevention: what have we learnt, and where do we go next?

Presenter: Raphael Micheroli
EULAR 2024
6:52

"Asymptomatic" Hyperuricemia: Innocent bystander or menacing foe?

Presenter: Francisca Sivera
EULAR 2024
Medical De
9:40

Medical Devices in Diabetes

Presenter: Anne Louise Peters
Specialty: Diabetes
Will SGLT2
9:12

Will SGLT2-inhibitors change the landscape?

Presenter: Apostolos Tsapas
Specialty: Diabetes
Innate imm
10:54

Innate immunity in pancreatic islet inflammation

Presenter: Decio L. Eizirik
Specialty: Diabetes
The artifi
5:30

The artificial beta cell. When will the dream become reality?

Presenter: Eric Renard
Specialty: Diabetes
Observatio
6:15

Observational study of insulin pump treatment

Presenter: Soffia Gudbjörnsdottir
Specialty: Diabetes
The eviden
7:34

The evidence for metformin is unclear?

Presenter: Rury Holman
Specialty: Diabetes
The ORIGIN
10:10

The ORIGIN Study And Legacy Effects

Presenter: Hertzel Gerstein
Specialty: Diabetes
EMPA-REG O
11:11

EMPA-REG OUTCOME - a long-term, outcom study of empagliflozin in pateints with T2D at high CV risk

Presenter: Hans-Juergen Woerle
Specialty: Diabetes
Principal
10:00

Principal investigator presenting the results of EMPA-REG OUTCOME trial

Presenter: Bernard Zinman
Specialty: Diabetes
Mathematic
7:40

Mathematic modelling of fibrinolysis

Presenter: Brittany Bannish
Pre and pe
2:02

Pre and perioperative factors modulate fibrinolysis in arthroplasty patients

Presenter: Drew Burleson
Cellular a
31:38

Cellular and mechanical modulators of fibrin structure

Presenter: Kraszimir Kolev
Platelets,
41:33

Platelets, NETs and Immunity

Presenter: Paul Kubes
Mechanisms
17:59

Mechanisms by which DNA, histones and NETs stabilise clots

Presenter: Imre Varju
Free fatty
3:31

Free fatty acids modulate thrombin activity ov fibrinogen and destabilise fibrin clots

Presenter: Anna Tanka-Salamon
Genetics o
31:21

Genetics of thrombosis

Presenter: David Ginsburg
Clinical I
6:21

Clinical Impact of Liraglutide as a Treatment of Obesity

Presenter: Babak Dehestani
Associatio
20:17

Association of GLP 1 Analogs and Agonists Administered for Obesity with Weight Loss and Adverse Events

Presenter: Michael Camilleri